USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride

Similar documents
TERBASMIN EXPECTORANTE SOLUCION

Prospectus: User information Astenolit solución oral

USER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride

USER INFORMATION PAMPHLET. Metalgial 500mg/ml oral drops in solution (sodium metamizole)

User Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG

User Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol)

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PACKAGE LEAFLET: INFORMATION FOR THE USER

PAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina

PACKAGE LEAFLET: INFORMATION FOR THE USER. EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection. Ephedrine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylo-COMOD

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

PACKAGE LEAFLET. Page 1 of 6

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nasonal 1 mg/ml neusspray, oplossing. Xylometazoline hydrochloride

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

NEW ZEALAND DATA SHEET

TREANA 5mg and 10mg Film-coated Tablets

IMPORTANT: PLEASE READ

Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)

PATIENT INFORMATION LEAFLET

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

Package leaflet: Information for the user Zirtek Allergy Relief for Children 1 mg/ml Oral Solution Cetirizine dihydrochloride

PACKAGE LEAFLET. Page 1 of 8

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Benylin Phlegm Cough plus Decongestant Syrup

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PATIENT INFORMATION LEAFLET BILOCOR RANGE

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PHARMACY ACTION COLD & FLU DAY & NIGHT paracetamol, pseudoephedrine hydrochloride, chlorphenamine maleate

Package leaflet: Information for the user Zirtek Allergy Relief 10 mg film-coated tablets Cetirizine dihydrochloride

1. What Betahistine dihydrochloride tablets is and what it is used for

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the patient

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package Information Leaflet: Information for the user. Calmaben Coated Tablets

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user Zirtek Allergy Relief 10 mg Film Coated Tablets Cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

Imodium 1 mg/5 ml oral solution

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

What is in this leaflet

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Dry Cough & Congestion Relief Oral Solution

PATIENT INFORMATION LEAFLET TEXAMER

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package Leaflet: Information for the user. Anti-Hist Allergy 10mg Film-Coated Tablets. Cetirizine dihydrochloride

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

TOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate

PATIENT INFORMATION LEAFLET AMLOC RANGE

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Sertraline KR 50 mg Tablets Sertraline KR 100 mg Tablets. Sertraline Hydrochloride

AVIOMARIN 50 mg tablets

METHYLDOPA 250 mg Film-coated Tablets

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

Package leaflet: Information for the patient. xylometazoline hydrochloride

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Clarinase Loratadine and Pseudoephedrine Sulfate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

PACKAGE LEAFLET: INFORMATION FOR THE USER Oxybutynin Hydrochloride 3mg Tablets

Package leaflet: Information for the user. Cetirelief Allergy 10mg film-coated tablets. Cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

Transcription:

USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without a prescription for the treatment of minor afflictions without the intervention of a doctor. However, you must use Senioral jarabe niños with care to obtain the best results. -Keep this prospectus; you may need to read it again. -If you have any doubts, consult your doctor or pharmacists. This medicine has been prescribed to you and must not be given to others. It may harm them, even when their symptoms are the same as yours. In this prospectus: 1. What are Senioral jarabe niños and what are they used for? 2. Before using Senioral jarabe niños 3. How to use Senioral jarabe niños 4. Possible adverse effects 5. Storage of Senioral jarabe niños 1.WHAT IS SENIORAL jarabe niños AND WHAT IS IT USED FOR? SENIORAL syrup for adults has two principal ingredients: clocinizine and phenylpropanolamine. Clocinizine belongs to the antihistamine group, drugs used for the alleviation of allergic reactions. Phenylpropanolamine belongs to the adrenergic agonist group, which are used for the alleviation of nasal congestion. SENIORAL syrup for adults is used solely for the temporary alleviation of nasal congestion in colds, rhinitis, and nasal congestion associated with sinusitis. 2. BEFORE TAKING SENIORAL jarabe niños Do not take SENIORAL jarabe niños -If you are allergic (hypersensitive) to phenylpropanolamine, clocinizine or any of the other components of SENIORAL jarabe niños. -If you have high blood pressure (arterial hypertension), if you have any thyroid illness (hyperthyroidism) or suffer heart problems (serious coronary illness or angina pectoris). -If you are taking any medicine for depression or for Parkinson s disease, which inhibits the mono-amino-oxide (IMAO) (see below: Use of other medicines). -With children under 2. Be especially careful with SENIORAL jarabe niños -Do not exceed the maximum recommended dose (see 3.How to take SENIORAL jarabe niños), as serious side effects can occur (see If you take more SENIORAL jarabe niños than you should).

-If you suffer from diabetes mellitus, have high ocular pressure (glaucoma) or present alterations of the prostate (prostatic hypertrophy) or urinary retention, as these conditions can worsen. Use of other medicines Inform your doctor or pharmacist if you are taking or have recently taken other medicines, including those without prescription. -If you use drugs that inhibit the mono-amino-oxide (IMAO) enzyme, which are used for depression (trancylcypromine, moclobemedide) or for Parkinson s disease (selegiline), serious side effects can occur which manifest themselves as strong headaches, sharp rises in temperature. If you have taken any of these medicines, wait a minimum of 15 days before taking SENIORAL jarabe niños. If you are not sure if your medication includes an IMAO drug, consult your doctor before taking SENIORAL jarabe niños. -If you are being treated with other medication, consult your doctor or pharmacist before taking SENIORAL jarabe niños. Pregnancy and breast feeding Consult your doctor or pharmacist before taking any medicine. Mothers who are breast feeding must not use this medicine, as it can pass through the milk to the child. Driving and the use of machines Do not drive or use machines because SENIORAL can diminish your capacity to concentrate and reflexes. Use in sportspeople We inform sportspeople that this medicine contains an ingredient that can produce a positive result in analytic doping tests. Important information about some of the components of SENIORAL jarabe niños. This medicine contains 0.87% of ethanol (alcohol) by volume, which corresponds to a quantity of 103mg per dose, which is equivalent to 2 ml of beer or 0.86 ml of wine. This medicine is prejudicial to those suffering from alcoholism. The alcohol content must be considered in the case of pregnant women, or those breast feeding, children or high risk groups, such as those with liver diseases or epilepsy. It can produce allergic reactions (possibly delayed) as it contains methyl parahydroxybenzoate (E-218). This medicine contains sucrose. If your doctor has indicated that you suffer from intolerance to certain sugars, consult with him/her before taking this medication. Patients with diabetes mellitus need to bear in mind that this medicine contains 12.3 g of sucrose per dose (15ml).

3. HOW TO TAKE SENIORAL jarabe niños Follow the instructions given by your doctor exactly. Consult your doctor or pharmacist if you have doubts. The standard dose is: Children between 2 and 5: The maximum daily dose is 7.5ml three times a day, to be taken before meals with a minimum gap of 6 hours between doses. Children between 5 and 12: The maximum daily dose is 15ml three times a day, to be taken before meals and with a minimum gap of 6 hours between doses. If symptoms do not improve after 5 days or are accompanied by a high temperature, you must consult your doctor before continuing the treatment. SENORIAL syrup for children is administered orally using the dosage glass. The syrup must be taken before meals. A minimum gap of 6 hours must be left between doses. Remember to take your medicine. Use in children Do not use with those under 2. If you take more SENIORAL jarabe niños than you should If you have taken a higher dose than recommended you may suffer cardiac and neurologic alterations. In this case a gastric wash is needed and the symptoms will need to be treated. Consult your doctor or pharmacist. If higher than recommended doses are taken these can cause nervousness, vertigo, palpitations, trembling, agitation and, very rarely hallucinations, convulsions and cerebral haemorrhages. If you have any of these symptoms, interrupt the use of this medicine immediately and consult your doctor. In the case of excessive or accidental ingestion of SENIORAL jarabe niños, immediately go to your doctor or the Emergency Department at your nearest hospital, or consult the Toxicology Information Service (telephone: 915620420), indicating the medicine and the amount ingested. If possible, take this information pamphlet with you. If you forgot to take SENIORAL jarabe niños Do not take a double dose to compensate the forgotten ones. Take your dose as soon as possible. If it is less than 6 hours till when you should take the next dose, wait until this time to take your spoonful of syrup. If you interrupt your treatment with SENIORAL jarabe niños Your doctor will indicate the length of your treatment with SENIORAL jarabe niños. If you stop before the date indicated by your doctor, the symptoms of your illness may return. If you have any doubts about the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS As with all medicines, SENIORAL jarabe niños can produce side effects, though not everyone suffers them. Cardiovascular effects: Alterations of pulse (palpitations, tachycardia), increased blood pressure (hypertension), which on occasion can be serious (hypertensive crisis). Effects on the nervous system: Intranquility, dizziness, lack of sleepiness, headaches, strange behaviour. Occasionally sedation or drowsiness can be produced. Other side effects can be gastrointestinal discomfort (nausea and vomiting), constipation, confusion, euphoria, visual alterations, dry mouth and difficulty urinating. If you consider that any of the side effects you suffer is serious or if you appreciate any side effect not mentioned in this pamphlet, inform your doctor or pharmacist. 5. CONSERVATION OF SENIORAL jarabe niños Keep out of reach and sight of children. Do not use SENIORAL jarabe niños after the expiry date which appears on the container. The expiry date is the last day of the month indicated. Keep in the original container. Medicines must not be disposed of in the drains or thrown away. Leave unwanted medicines and containers at the SIGRE point in a chemist. Ask your pharmacist how to dispose of any containers or unneeded medicines. This way you will help look after the environment. 6. ADDITIONAL INFORMATION Composition of SENIORAL jarabe niños -The principal components are: clocinizine dihydrochloride and phenylpropanolamine hydrochloride. Each 100ml of syrup contains 15mg of clocinizine dihydrochloride and 130mg of phenylpropanolamine hydrochloride. Each 15ml (a dose) of syrup contains: clocinizine dihydrochloride, 2.25mg and phenylpropanolamine hydrochloride, 19.5mg. -The other components are: sucrose, ethanol, methyl parahydroxybenzoate (E-218), extract of cassis 30 GS 750, concentrated hydrochloric acid and purified water. Product appearance and container contents SENIORAL jarabe niños is a reddish syrup, which is presented in cases containing 150ml jars and a small dosage glass, with various measures marked. Holder of the authorisation for the commercialisation and fabrication of the product. LABORATORIOS ERN, S.A. Pedro IV, 499-08020 Barcelona, España

Responsable for fabrication. LABORATORIOS ERN, S.A. Pedro IV, 499-08020 Barcelona, España Laboratorios ERN, S.A. Gorcs i LLadó, 188 08210 Barberá del Vallés, Barcelona. España. This pamphlet was approved in February 2001. Detailed and updated information about this product is available on the webpage of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/